Rophibio, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration (NCT06470373) | Rophibio, Inc. | 2025-07-01 |
Track Rophibio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.